StonvexLoading…
StonvexStonvexStonvexCore line items from TIC's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $488.03M | $1.53B | $1.02B | $548.14M |
Operating Income | $-29.06M | $-17.10M | $2.40M | $8.91M |
Net Income | $-41.55M | $-87.12M | $-39.92M | $-233.00K |
EPS (Diluted) | Not available | Not available | $-0.08 | Not available |
Total Assets | $4.33B | $4.40B | $4.22B | $2.24B |
Total Liabilities | $2.20B | $2.22B | $2.27B | $1.06B |
Cash & Equivalents | $426.56M | $439.54M | $164.43M | $130.06M |
Free Cash Flow OCF − CapEx | $4.23M | $61.26M | $24.14M | $13.81M |
Shares Outstanding | 221.04M | 220.49M | 202.04M | 121.48M |